# clm_56EFD8BFD444

subject: Amgen (/record/amgen.md)  
predicate: quarterly_revenue  
value: 9,557,000,000 United States dollar  
valid_from: 2025-09-30  
valid_to: 2026-03-31  
published: 2025-11-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_BA3B03AF2A85  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly revenue: 9,557,000,000 United States dollar", as of 2025-09-30 (until 2026-03-31). Claim clm_56EFD8BFD444, https://asof.is/claim/clm_56EFD8BFD444, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-11-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm (primary, SEC EDGAR 10-Q Q3 FY2025, published 2025-11-05)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_revenue | 9,179,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_56EFD8BFD444](/claim/clm_56EFD8BFD444.md) | [clm_DF01174105A5](/claim/clm_DF01174105A5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.